NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
11.57
-0.15 (-1.28%)
Nov 13, 2026, 1:09 PM EST - Market open

NovoCure Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-121.73-136.23-168.63-207.04-92.53-58.35
Depreciation & Amortization
15.5513.139.879.79.579.17
Other Amortization
5.155.155.144.594.354.42
Asset Writedown & Restructuring Costs
6.234.851.160.490.960.65
Loss (Gain) From Sale of Investments
-26.89-26.89-28.27-26.4-4.83-0.24
Stock-Based Compensation
117.32104.83160.04115.61106.9694.9
Other Operating Activities
10.096.2-2.020.07-5.473.14
Change in Accounts Receivable
-35.62-38.94-26.3629.412.555.27
Change in Inventory
-1.95-5.672.57-8.92-4.342.48
Change in Accounts Payable
31.2718.9619.1114.8714.2627.78
Change in Other Net Operating Assets
-0.145.571.04-5.71-0.67-6.46
Operating Cash Flow
-0.72-49.03-26.37-73.3430.7982.76
Operating Cash Flow Growth
-----62.80%-16.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-23.89-26.65-42.86-27.09-21.36-24.17
Investment in Securities
338.34463.92-97.39211.24-118.6-120.66
Investing Cash Flow
314.46437.28-140.24184.15-139.96-144.83

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-99.9896.92---
Long-Term Debt Repaid
--560.95-12.91-0.01-0.03-0.03
Net Debt Issued (Repaid)
-560.95-460.9784.01-0.01-0.03-0.03
Issuance of Common Stock
10.189.776.3115.815.5225.73
Repurchase of Common Stock
-0.7-0.15----
Financing Cash Flow
-551.47-451.3490.3215.7915.4925.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.070.39-0.170.13-0.1-0.19
Net Cash Flow
-237.8-62.7-76.47126.73-93.78-36.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24.61-75.68-69.22-100.439.4358.59
Free Cash Flow Growth
-----83.90%-30.40%
Free Cash Flow Margin
-3.39%-11.55%-11.44%-19.72%1.75%10.95%
Free Cash Flow Per Share
-0.21-0.68-0.64-0.940.090.57
Levered Free Cash Flow
9-37.988.6-1.9851.76104.89
Unlevered Free Cash Flow
22.69-30.9612-3.2150.55103.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.3413.417.710.010.040.1
Cash Income Tax Paid
9.6330.6723.4613.675.483.11
Change in Working Capital
-6.43-20.08-3.6529.6611.829.07
SEC Filings: 10-K · 10-Q